Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CVI-HBV-001 in Hepatitis B Vaccine Non-Responders
NCT02692170Phase 2Completed
- Sponsor
- AriBio Lab
- Start
- Dec 2012
- Primary completion
- May 2015
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of hepatitis B vaccine (CVI-HBV-001) in hepatitis B (HBV), sponsored by AriBio Lab. Started Dec 2012; status: completed.
02
Drugs
hepatitis B vaccine (CVI-HBV-001)
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02692170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02692170.